Similar articles

• Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network.

  Drazen JM, Israel E, Boushey HA, Chinchilli VM, Fahy JV, Fish JE, Lazarus SC, Lemanske RF, Martin RJ, Peters SP, Sorkness C, Szefler SJ. Drazen JM, et al. N Engl J Med. 1996 Sep 19;335(12):841-7. doi: 10.1056/NEJM199609193351202. N Engl J Med. 1996. PMID: 8778601 Clinical Trial.
• Excess mortality in patients with asthma on long-acting beta2-agonists.

  Hasford J, Virchow JC. Hasford J, et al. Eur Respir J. 2006 Nov;28(5):900-2. doi: 10.1183/09031936.00085606. Eur Respir J. 2006. PMID: 17074917 No abstract available.
• Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.

  Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF Jr, Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Israel E, et al. Lancet. 2004 Oct 23-29;364(9444):1505-12. doi: 10.1016/S0140-6736(04)17273-5. Lancet. 2004. PMID: 15500895 Clinical Trial.
• [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].

  Kimura T, Adachi M. Kimura T, et al. Nihon Rinsho. 2001 Oct;59(10):1992-9. Nihon Rinsho. 2001. PMID: 11676144 Review. Japanese.
• Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.

  Prenner BM. Prenner BM. Curr Opin Pulm Med. 2008 Jan;14(1):57-63. doi: 10.1097/MCP.0b013e3282f27121. Curr Opin Pulm Med. 2008. PMID: 18043276 Review.